Montreal resident donates to stem cell research hoping it will help her heart Pipa News – PiPa News

Doctors say MUHC has embarked on stem cell research with serious potential to treat a range of diseases, and some of that work was made possible by someone who hoped it would help her. Sharon Steinberg proudly says that she works out three times a week. She is in her 80s and has been exercising as prescribed by her doctor after experiencing troublesome symptoms.

Read more
Utilization of Modified Induced Pluripotent Stem Cells as the Advance | OPTH – Dove Medical Press

Introduction Glaucoma is one of the optic neuropathy disorders characterized by the progressive degeneration of retinal ganglion cells (RGC), which eventually lead to cupping of the optic disc and decreased visual field.1 Glaucoma is also closely related to an increase in intraocular pressure caused by the damage of trabecular meshwork (TBM), which results in optic nerve damage, characterized by the loss of retinal ganglion cells.2,3 Globally, in 2020, more than 76 million people are suffering from glaucoma, and it is expected to increase to 111.8 million people by 2040.4,5 Glaucoma is also a severe and complex medical problem because it often causes blindness. According to the World Health Organization (WHO), the most common causes of blindness are cataracts (51%), followed by glaucoma (8%), and age-related macular degeneration (5%).6 This data shows that glaucoma is the worlds second most common cause of blindness after cataracts. Symptoms that are often asymptomatic at an early stage and the low public awareness have contributed to the disorders seriousness. Handling and treating glaucoma cases is difficult, especially because no therapy can cure glaucoma. Current treatment, both medical and surgical, is focused solely on lowering intraocular pressure

Read more
Global Cancer Stem Cells Market Estimated to Reach $1,722.7 Million by 2026 and Grow at 10.3% CAGR in the 2019 to 2026 Timeframe | [180-Pages] Report…

The global cancer stem cells market expected to grow by 2026 due to rising prevalence of cancer. The breast cancer sub-segment is expected to be highly profitable. Market in the North America region is expected to be highly lucrative. NEW YORK, Aug. 19, 2022 /PRNewswire/ --Research Dive has added a new report to its offering titled, "Cancer Stem Cells Market, By Cancer Form (Breast, Blood, Lung, Brain, Colorectal, Pancreatic, Bladder, Liver), By Application (Targeted CSCs, Stem Cell Based Cancer Therapy): Global Opportunity Analysis and Industry Forecast, 20192026"

Read more
Mouse embryos with beating hearts have been created entirely in the lab – Freethink

Mouse embryos have now been grown completely from stem cells, without sperm or eggs and outside a mouse womb. The breakthrough, from a lab at the Weizmann Institute of Science, appears to represent an important step in understanding the development of organs, disease, and life as a whole. It may also be just the start. As soon as the science starts to move into a place where its feasible to go from a stem cell population in a Petri dish all the way through to organ development which suggests one day it will be possible to go all the way to creating a living organism its a pretty wild and remarkable time, Paul Tesar, a developmental biologist at Case Western Reserve unaffiliated with the work, told STATs Megan Molteni.

Read more